Pharmica Consulting has joined ProPharma Group.

Effective February 1, 2022, this site will no longer be accessible, and you will automatically be directed to our regulatory, clinical, and compliance services supporting clients throughout the full product lifecycle. Learn about our expanded services.

Inside Investigator Meetings (Part 4 – The Root of the Matter)

Regardless of how one looks at the current state of investigator meetings, there is no question there is room for improvement. Like any improvement initiative, the first question the sponsor needs to ask is, “How does this benefit the bottom line?” The value of an investigator meeting needs to be properly defined and evaluated. Any subsequent[…]